Acute rheumatic fever References from op ghai essential of pediatrics and nelson pediatrics

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Searching Images

acute rheumatic fever erythema marginatum subcutaneous nodules Jones criteria

Clinical photograph (dermatology) showing erythema marginatum, an annular, non-itchy rash characteristic of acute rheumatic fever. The image depicts multiple pink to red circular to oval patches on the skin of the lower extremity with sharply demarcated, serpiginous margins and centers that appear pale or clearing. Lesions are non-vesicular, smooth-surfaced, and vary in size, with a tendency to migrate or transiently flare. The distribution favors the trunk and proximal limbs and typically spares the face. On close inspection the patches lack scaling and crusting, consistent with erythema marginatum rather than dermatitis or fungal infection. This cutaneous manifestation is part of the Jones criteria and may correlate with concurrent migratory polyarthritis, fever, and evidence of preceding group A Streptococcus infection. Histologic features (if biopsied) would show superficial perivascular lymphocytic infiltrate and dermal edema with minimal epidermal changes; clinically, the rash is a marker for systemic inflammatory involvement. Differential considerations include urticaria, erythema multiforme, tinea corporis, pityriasis rosea, and other annular dermatoses. Clinically, recognizing erythema marginatum prompts evaluation for acute rheumatic fever and guides management including antibiotic therapy and anti-inflammatory treatment. The image serves educational and diagnostic-reference purposes for dermatology, pediatrics, infectious diseases, and rheumatology training.

Clinical photograph (dermatology) showing erythema marginatum, an annular, non-itchy rash characteristic of acute rheumatic fever. The image depicts multiple pink to red circular to oval patches on the skin of the lower extremity with sharply demarcated, serpiginous margins and centers that appear pale or clearing. Lesions are non-vesicular, smooth-surfaced, and vary in size, with a tendency to migrate or transiently flare. The distribution favors the trunk and proximal limbs and typically spares the face. On close inspection the patches lack scaling and crusting, consistent with erythema marginatum rather than dermatitis or fungal infection. This cutaneous manifestation is part of the Jones criteria and may correlate with concurrent migratory polyarthritis, fever, and evidence of preceding group A Streptococcus infection. Histologic features (if biopsied) would show superficial perivascular lymphocytic infiltrate and dermal edema with minimal epidermal changes; clinically, the rash is a marker for systemic inflammatory involvement. Differential considerations include urticaria, erythema multiforme, tinea corporis, pityriasis rosea, and other annular dermatoses. Clinically, recognizing erythema marginatum prompts evaluation for acute rheumatic fever and guides management including antibiotic therapy and anti-inflammatory treatment. The image serves educational and diagnostic-reference purposes for dermatology, pediatrics, infectious diseases, and rheumatology training.

Clinical photograph showing the dorsal surface of a human hand, specifically focusing on the interphalangeal joints. Two prominent subcutaneous nodules are visible over the joint space, indicated by black arrows. These nodules appear as firm, well-circumscribed, painless elevations under the skin. They are flesh-colored to slightly pale, with smooth overlying skin and no signs of acute inflammation, erythema, or ulceration. This finding is a characteristic major Jones criterion for the diagnosis of acute rheumatic fever. The image serves as an educational tool for identifying extra-articular manifestations of rheumatological and post-streptococcal conditions in a clinical setting.

Clinical photograph showing the dorsal surface of a human hand, specifically focusing on the interphalangeal joints. Two prominent subcutaneous nodules are visible over the joint space, indicated by black arrows. These nodules appear as firm, well-circumscribed, painless elevations under the skin. They are flesh-colored to slightly pale, with smooth overlying skin and no signs of acute inflammation, erythema, or ulceration. This finding is a characteristic major Jones criterion for the diagnosis of acute rheumatic fever. The image serves as an educational tool for identifying extra-articular manifestations of rheumatological and post-streptococcal conditions in a clinical setting.

This is a clinical dermatology photograph capturing erythema marginatum on the skin of the lower limb. The modality is Clinical photography; technique: naked-eye, color-balanced image. The observed lesions are erythematous, annular plaques with central clearing and pale, sometimes hypopigmented centers. Lesions appear as rings with slightly raised margins and a uniform pink-to red hue; they range from 0.5 to 2 cm in diameter and may coalesce into larger plaques. The rash is typically non-pruritic and evanescent, with temporary eruption that may migrate or fade over hours to days; distribution commonly involves the trunk and proximal limbs, with sparing of the face. The image may reflect erythema marginatum, a cutaneous manifestation associated with acute rheumatic fever and autoimmune inflammatory processes. In longer-standing presentations, the rash signals preceding or concurrent carditis and migratory arthritis; therefore clinical correlation with recent group A Streptococcus infection, elevated ASO titers, and echocardiography is essential. Differential diagnoses include urticaria, erythema multiforme, pityriasis rosea, and drug-induced eruptions. Clinically, this finding has diagnostic significance as a major criterion in rheumatic fever per Jones criteria; management focuses on antibiotic treatment of streptococcal infection and secondary prophylaxis. This image serves educational purposes for medical students, residents, and researchers studying connective tissue disease and pediatric rheumatology.

This is a clinical dermatology photograph capturing erythema marginatum on the skin of the lower limb. The modality is Clinical photography; technique: naked-eye, color-balanced image. The observed lesions are erythematous, annular plaques with central clearing and pale, sometimes hypopigmented centers. Lesions appear as rings with slightly raised margins and a uniform pink-to red hue; they range from 0.5 to 2 cm in diameter and may coalesce into larger plaques. The rash is typically non-pruritic and evanescent, with temporary eruption that may migrate or fade over hours to days; distribution commonly involves the trunk and proximal limbs, with sparing of the face. The image may reflect erythema marginatum, a cutaneous manifestation associated with acute rheumatic fever and autoimmune inflammatory processes. In longer-standing presentations, the rash signals preceding or concurrent carditis and migratory arthritis; therefore clinical correlation with recent group A Streptococcus infection, elevated ASO titers, and echocardiography is essential. Differential diagnoses include urticaria, erythema multiforme, pityriasis rosea, and drug-induced eruptions. Clinically, this finding has diagnostic significance as a major criterion in rheumatic fever per Jones criteria; management focuses on antibiotic treatment of streptococcal infection and secondary prophylaxis. This image serves educational purposes for medical students, residents, and researchers studying connective tissue disease and pediatric rheumatology.

This clinical photograph displays a close-up view of the right upper extremity, specifically the extensor surface of the elbow region. The primary clinical finding is the presence of multiple, small subcutaneous nodules. These nodules appear as firm, rounded, non-tender-looking elevations beneath the skin surface, typically measuring less than 1 cm in diameter. The overlying skin is intact, displaying normal pigmentation and texture without visible erythema, warmth, or ulceration. Prominent hair follicles are visible as dark punctate spots across the skin. In a clinical context involving polyarthralgia and carditis, these nodules are a major Jones criterion for the diagnosis of acute rheumatic fever (ARF). This image serves as a teaching tool for medical students and clinicians to recognize the dermatological manifestations of systemic streptococcal-related diseases and rheumatological disorders.

This clinical photograph displays a close-up view of the right upper extremity, specifically the extensor surface of the elbow region. The primary clinical finding is the presence of multiple, small subcutaneous nodules. These nodules appear as firm, rounded, non-tender-looking elevations beneath the skin surface, typically measuring less than 1 cm in diameter. The overlying skin is intact, displaying normal pigmentation and texture without visible erythema, warmth, or ulceration. Prominent hair follicles are visible as dark punctate spots across the skin. In a clinical context involving polyarthralgia and carditis, these nodules are a major Jones criterion for the diagnosis of acute rheumatic fever (ARF). This image serves as a teaching tool for medical students and clinicians to recognize the dermatological manifestations of systemic streptococcal-related diseases and rheumatological disorders.

Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Searching PubMed

"acute rheumatic fever" Jones criteria management

I now have all the information needed. Let me compile the comprehensive answer.

Acute Rheumatic Fever (ARF)

Note on requested references: The textbook library does not contain OP Ghai's Essential Pediatrics or Nelson's Textbook of Pediatrics directly. The content below draws on clinically equivalent authoritative sources: Red Book 2021 (AAP), Harriet Lane Handbook 23e (Johns Hopkins), Goldman-Cecil Medicine, Tintinalli's Emergency Medicine, and Firestein & Kelley's Rheumatology - all of which present the same core ARF framework used in OP Ghai and Nelson.

Definition

Acute rheumatic fever is an immunologically mediated, non-suppurative delayed sequela of group A beta-hemolytic streptococcal (GAS/GABHS) pharyngitis. It primarily targets the connective tissue of the heart, joints, CNS, and skin. Rheumatic heart disease is its long-term sequela.

Epidemiology

  • Most common in children 5-15 years of age
  • Affects males and females equally; rheumatic heart disease is more common in women
  • Peak prevalence of rheumatic heart disease in the 3rd-4th decades (due to cumulative valve damage from recurrent attacks)
  • Global burden: ~33 million prevalent cases, ~300,000 annual deaths
  • Highest rates: Oceania, South Asia, central sub-Saharan Africa, indigenous populations of Australia
  • Incidence has fallen in developed countries over the past 50 years; sporadic outbreaks still occur in North America with virulent strains (mucoid types 3, 5, and 18)

Etiopathogenesis

ARF follows pharyngeal infection with specific rheumatogenic strains of GAS (cutaneous GAS infections do NOT cause ARF). The pathogenesis involves molecular mimicry:
  • Similarities between streptococcal proteins (M protein) and human cardiac proteins trigger cross-reactive antibodies and T cells
  • Carditis - antibody binding + T-cell infiltration of heart
  • Arthritis - immune complex deposition in joints
  • Chorea - antibody binding to basal ganglia
  • Skin lesions - delayed hypersensitivity reactions
Latency: ARF develops approximately 2-3 weeks (range 1-5 weeks) after streptococcal pharyngitis.

Clinical Features (Major Jones Criteria - CASES)

FeatureFrequencyKey Points
Carditis>50%Pancarditis - pericarditis, myocarditis, endocarditis (valvulitis)
Arthritis60-75%Migratory, fleeting, polyarticular, large joints, salicylate-sensitive
Sydenham's Chorea~30%Involuntary, non-rhythmic, purposeless movements; stops during sleep; more pronounced on one side
Erythema marginatum<10%Pink, non-pruritic, blanching, serpiginous rash on trunk and proximal limbs (spares face)
Subcutaneous nodules<10%0.5-2 cm, painless, over bony prominences/extensor tendons
Carditis details: The most significant manifestation. Mitral valve is almost always affected (valvular regurgitation initially). Aortic valve in 20-30%. Pulmonic valve rarely. Clinical features: new or changing murmurs, cardiomegaly, CHF, pericarditis. "Rapid sleeping pulse" and tachycardia out of proportion to fever are characteristic.
Arthritis details: Synovial fluid is sterile with lymphocyte predominance. Dramatically responsive to NSAIDs/salicylates - failure to respond should prompt reconsideration of diagnosis.
Chorea note: Because of the long latency between GAS infection and appearance of chorea, laboratory evidence of antecedent streptococcal infection may be lacking when chorea is the sole criterion - ARF can still be diagnosed in this setting.

Minor Criteria

Low-Risk PopulationsModerate/High-Risk Populations
PolyarthralgiaMonoarthralgia
Fever ≥38.5°CFever ≥38°C
ESR ≥60 mm/h and/or CRP ≥3.0 mg/dLESR ≥30 mm/h and/or CRP ≥3.0 mg/dL
Prolonged PR interval (if carditis not a major criterion)Prolonged PR interval (if carditis not a major criterion)

Revised Jones Criteria (2015 AHA)

The 2015 revision (Gewitz et al., Circulation 2015;131:1806-1818) introduced population-specific criteria:
Low-risk populations = ARF incidence <2 per 100,000 school-aged children/year OR rheumatic heart disease prevalence ≤1 per 1,000 population/year (USA, Canada, Europe)
Moderate/high-risk populations = ARF-endemic regions (Africa, Asia-Pacific, Australia's indigenous population, South Asia) - India falls here.

Diagnostic Rule

ScenarioCriteria Required
Initial ARF2 major OR 1 major + 2 minor criteria
Recurrent ARF2 major OR 1 major + 2 minor OR 3 minor criteria
Key additions in 2015:
  • Subclinical carditis on echocardiogram (without clinical findings) now counts as a major criterion
  • In high-risk populations: monoarthritis/monoarthralgia qualifies as major/minor criterion respectively (previously only polyarthritis qualified)
  • Evidence of antecedent GAS infection is mandatory (except when chorea is the sole criterion)
Evidence of antecedent GAS infection:
  • Positive throat culture for GAS
  • Positive rapid antigen test
  • Elevated or rising ASO titer
  • Elevated anti-DNase B titer

Laboratory Investigations

TestSignificance
ASO titerElevated in 80% of ARF; peak 4-6 weeks post-infection
Anti-DNase BMore sensitive than ASO (especially after skin infections)
ESR, CRPElevated (acute phase); ESR may remain elevated longer
CBCNormochromic normocytic anemia, leukocytosis
ECGProlonged PR interval (1st degree AV block) in carditis
EchoSubclinical valvulitis; confirms carditis; baseline for follow-up
Throat cultureMay be negative by the time ARF presents

Differential Diagnosis

  • Septic/reactive arthritis (non-migratory, joint may be hot and red)
  • Juvenile idiopathic arthritis
  • Infective endocarditis
  • Viral arthritis
  • Lyme disease
  • SLE
  • Leukemia/malignancy
  • Poststreptococcal reactive arthritis (PSRA): distinct entity - nonmigratory mono/oligoarthritis, starts sooner (~10 days vs ~21 days after GAS), more severe/prolonged, salicylate-resistant, older patients, NO carditis or other major criteria

Treatment

1. Eradication of GAS (Primary Treatment)

  • Benzathine penicillin G IM (single dose): 600,000 units if <27 kg; 1.2 million units if ≥27 kg
  • Penicillin V orally for 10 days: alternative
  • Amoxicillin orally for 10 days: alternative
  • Erythromycin (or azithromycin): for penicillin-allergic patients
  • Treat even if throat culture is negative

2. Anti-inflammatory Therapy

  • Arthritis: Aspirin 80-100 mg/kg/day in divided doses (max 4-8 g/day) - continue 1-2 weeks after all symptoms resolve; naproxen (10-20 mg/kg/day BD) is an alternative; NSAIDs should not be stopped at just joint symptom resolution
  • Carditis: NSAIDs + heart failure management (diuretics, ACE inhibitors/ARBs, fluid restriction, bed rest); systemic glucocorticoids in severe cases (limited evidence)
  • Chorea: Usually self-limiting (resolves in weeks to months); haloperidol or valproate if severe

3. Bed Rest

  • Recommended during acute phase; activity restriction for carditis

4. Hospitalization

  • Advised in the early stages until diagnosis is confirmed

Secondary Prophylaxis

Long-term antibiotic prophylaxis is mandatory to prevent recurrent GAS infections and cumulative cardiac damage.
CategoryDuration
ARF without carditis5 years from last episode OR until age 21 (whichever is longer)
ARF with carditis, no residual valve disease10 years from last episode OR until age 21 (whichever is longer)
ARF with carditis + residual valvular disease10 years from last episode OR until age 40 (whichever is longer); consider lifelong if severe valve disease or ongoing exposure risk
Preferred regimen:
  • Benzathine penicillin G 1.2 million units IM every 4 weeks (most reliable; every 3 weeks in high-risk areas)
  • Penicillin V 250 mg orally twice daily (alternative, adherence-dependent)
  • Sulfadiazine 0.5 g/day (<27 kg) or 1 g/day (≥27 kg): alternative
  • Azithromycin 250 mg/day orally: for penicillin-allergic patients
A 2024 Cochrane systematic review (Bray et al., PMID 39312290) supports long-term prophylaxis for prevention of ARF recurrence and progression to rheumatic heart disease, though notes that high-quality RCT data for optimal duration remain limited.

Prognosis

  • Symptoms usually persist 2-4 weeks
  • 35-70% of patients progress to chronic rheumatic heart disease despite acute treatment
  • Resolution of carditis most likely in the first year; patients without carditis rarely develop it later
  • Recurrent ARF increases cumulative valve damage
  • Mitral valve affected in nearly 100% of rheumatic heart disease; aortic valve in 20-30%
  • Mitral regurgitation → most common early; mitral stenosis → most common cause of mitral stenosis worldwide (late scarring)

Clinical Images

Erythema marginatum - a major Jones criterion:
Erythema marginatum - annular non-pruritic rash of ARF
Subcutaneous nodules over interphalangeal joints (Jones criterion):
Subcutaneous nodules over knuckles in ARF
Subcutaneous nodules over elbow extensor surface:
Subcutaneous nodules over elbow - ARF

Key Memory Aid

Major criteria (CASES): Carditis, Arthritis (migratory polyarthritis), Sydenham's chorea, Erythema marginatum, Subcutaneous nodules
Minor criteria: Fever, Arthralgia, Elevated ESR/CRP, PR prolongation, Previous ARF history (in older criteria)

Sources: Red Book 2021 (AAP Report on Infectious Diseases), Harriet Lane Handbook 23e, Goldman-Cecil Medicine International Edition, Tintinalli's Emergency Medicine 9e, Firestein & Kelley's Textbook of Rheumatology. The 2015 Jones Criteria are adapted from Gewitz MH et al., Circulation 2015;131(20):1806-1818.
This is a shared conversation. Sign in to Orris to start your own chat.